Debra D. O'Gorman


Debra D. O'Gorman


New York | Three Bryant Park, 1095 Avenue of the Americas, New York, NY, United States of America 10036-6797
+1 212 698 3593 | +1 212 698 3599


Debra D. O’Gorman is a member of Dechert’s Product Liability and Mass Torts group. 

Ms. O'Gorman counsels clients in product liability and mass tort litigation, particularly in product liability actions involving prescription and over the counter drugs. She is experienced in leading all aspects of major disputes, including managing fact and expert discovery, taking and defending depositions, briefing a wide-range of motions, coordinating with co-defendant counsel, appearing and arguing in courts around the country and advising clients on litigation strategy.  Most recently, she represented Purdue Pharma in In re National Prescription Opiate Litigation, MDL 2804, N.D. Ohio (J. Polster), and related state court litigation, including serving as lead counsel for Purdue in numerous actions brought by state attorneys general.  Ms. O'Gorman served as discovery counsel in Multidistrict Litigation and state court cases involving testosterone replacement therapy, conducting dozens of fact and expert depositions, including several experts who were successfully excluded following Daubert challenges. Ms. O'Gorman was a key member of several trial teams in cases around the country alleging injury from Tylenol use.

In addition, Ms. O'Gorman has extensive experience in sovereign, creditors' rights, insolvency and bondholder litigation, handling complex and contentious multinational litigation. Ms. O'Gorman was an integral member of the Dechert team “highly commended” by the Financial Times in 2014 for its representation of Argentina's largest creditor - with claims for over US$3 billion–in multinational litigation and judgment enforcement proceedings. Dechert's representation was subsequently awarded the Grand Prize for Global Dispute of the Year (2016) by The American Lawyer for the Argentina debt default litigation and settlement. The team obtained the first ruling from a U.S. court that a central bank is the alter ego of its parent state, the first attachment of assets at the Bank for International Settlements in Basel Switzerland, the arrest of the Argentine Naval frigate ARA Libertad in Ghana, an injunction prohibiting Argentina from making payments on its restricted bonds without making ratable payments to holders of its defaulted bonds, and an order piercing the corporate veil between the Panamanian law firm Mossack Fonseca (of Panama Papers fame) and its Nevada affiliate.

Ms. O’Gorman was also a member of the Dechert litigation team recognized by the Financial Times as one of the Top U.S. Innovative Law Firms in 2013 for its “standout” work for creditors in the cross-border insolvency of Vitro S.A.B. de C.V. Often called “the case that saved the emerging markets,” this precedent-setting dispute marked the first time the U.S. courts refused to enforce a foreign plan of reorganization.

Ms. O'Gorman has played an active role on numerous trial teams. She presented the sole witness in a trial that resulted in an US$85 million judgment on behalf of creditors of the Democratic Republic of Congo in a lawsuit to recover on defaulted sovereign debt and in the fall of 2014 she served as the primary trial attorney for a creditor/objector in the City of Detroit bankruptcy proceeding.

Ms. O'Gorman is also actively committed to pro bono initiatives. She heads the firm’s involvement in a program to provide legal advice to litigants in family court throughout New York City and has received pro bono awards from several organizations.

  • University at Albany, State University of New York, B.S., 1987, cum laude
  • Fordham University School of Law, J.D., 1990
  • New York
  • Connecticut
  • United States Court of Appeals for the Second Circuit
  • United States District Court for the District of New Jersey
  • United States District Court for the Eastern District of New York
  • United States District Court for the Southern District of New York
  • Lead attorney for Purdue Pharma in numerous actions brought by state attorneys general related to opioids.
  • Discovery counsel for a manufacturer of testosterone replacement therapy in MDL and state court cases.
  • Member of the trial team in cases around the country alleging injury from Tylenol.
  • Member of the international team representing Argentina’s largest creditor, NML Capital, Ltd., in litigation and judgment enforcement proceedings spanning 11 countries on four continents.
  • Member of the team representing an ad hoc group of creditors of Mexican glass manufacturer Vitro S.A.B. de C.V. and its global subsidiaries in litigation and related bankruptcy proceedings in the United States, Mexico and elsewhere.
  • Member of the team representing a creditor for the Indonesian wood pulp and paper producers PT Lontar and PT Indah Kiat in judgment enforcement, insolvency and scheme of arrangement proceedings in the United States, the United Kingdom, Hong Kong, Singapore and Ontario.
  • Co-trial counsel for creditors of the Democratic Republic of Congo in an US$100 million lawsuit to recover on defaulted sovereign debt.
  • Trial counsel for Macomb County Public Works Commission in an objection to the City of Detroit’s Plan of Reorganization.
Speaking Engagements
  • New Global Foreign Sovereign Immunity Norms and Pressures — 2017 Section of International Law Spring Meeting, Washington, DC (April 28, 2017)